Clinical course of severe esophagitis following bevacizumab therapy.
Korean J Intern Med
; 37(1): 243-244, 2022 Jan.
Article
in En
| MEDLINE
| ID: mdl-34126704
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Esophagitis, Peptic
/
Esophagitis
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Korean J Intern Med
Journal subject:
MEDICINA INTERNA
Year:
2022
Document type:
Article
Country of publication:
Korea (South)